Perthera AI

📍 McLean, United States🗓 Founded 2012👥 30 employees💰 Last funded May 2019
Perthera AI is an oncology company that has pioneered the use of advanced multi-omic molecular analysis combined with a comprehensive "data lake" of patient specific outcomes and medical history to advise doctors & patients on optimal treatment options through the Oncology Operating System™. Perthera uses AI to identify the best drugs available for that individual, giving patients a 'performance prediction score' for every available therapeutic. The Perthera method and Oncology OS™ have been published and clinical proven to increase survival rates for thousands of patients, and are the best resource available today for oncologists in their treatment decision-making process. Perthera's clients & partners include Mayo Clinic, Pfizer, AstraZeneca, Novartis, the Department of Defense, and many others.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2012
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Perthera AI?
Perthera AI has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Perthera AI last raise funding?
The most recent investment in Perthera AI recorded on gritt.io was in May 2019.
When was Perthera AI founded?
Perthera AI was founded in 2012.
What industry is Perthera AI in?
Perthera AI operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Perthera AI based?
Perthera AI is headquartered in McLean, United States.